Ionis Pharmaceuticals Stock Forecast for 2023 - 2025 - 2030

Updated on 06/04/2023

Stock Rating
9
Price Target
$50.00
Consensus
Outperform
Upside
19.76%
Analysts
6
Stock Rating
9
Upside
19.76%
Analysts
6
Price Target
$50.00

Ionis Pharmaceuticals Stock Forecast and Price Target

The average price target of $50.00 for Ionis Pharmaceuticals's stock set by six distinguished analysts in recent weeks would represent a potential upside of approximately 19.76% from the last closing price in June, 2023 if reached by the end of the year. This potential increase is based on a high estimate of $92.00 and a low estimate of $26.00. If you are interested in IONS stock, it is important to also consider its competitors.

$50.00

19.76% Upside

Outperform
Outperform

Ionis Pharmaceuticals Fair Value Forecast for 2023 - 2025 - 2030

Ionis Pharmaceuticals's Price has decreased by 62.56% In the last two years, from $32.85 to $12.30. In the next year, analysts predict that Fair Value will jump to $44.43 – up 261.19% from the current level. Looking ahead to eight years, experts forecast that Fair Value will grow by 658.93%.

2023 Fair Value Forecast
$44.43
2024 Fair Value Forecast
$49.40
2025 Fair Value Forecast
$54.93
2026 Fair Value Forecast
$61.07
2027 Fair Value Forecast
$67.91
2028 Fair Value Forecast
$75.50
2029 Fair Value Forecast
$83.95
2030 Fair Value Forecast
$93.35
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
PFE Stock Forecast Pfizer Inc Outperform 3
$38.36 Buy/Sell $47.96 37.25%
AMGN Stock Forecast Amgen Inc Hold 7
$218.07 Buy/Sell $268.00 27.48%
SAN Stock Forecast Sanofi Outperform 10
91.12€ Buy/Sell 108.44€ 20.72%
REGN Stock Forecast Regeneron Pharmaceuticals Inc Outperform 2
$739.95 Buy/Sell $796.73 5.68%
MRNA Stock Forecast Moderna Outperform 11
$130.51 Buy/Sell $0.00 63.59%

Ionis Pharmaceuticals Revenue Forecast for 2023 - 2025 - 2030

Ionis Pharmaceuticals's Revenue has decreased by 27.81% In the last two years, from $1.12B to $810.46M. In the following year, the 20 analysts surveyed believe that Ionis Pharmaceuticals's Revenue will decrease by 17.80%, reaching $666.18M. Looking ahead to eight years, experts forecast that Revenue will grow by 326.99%.

2023 Rev Forecast
$0.67B
2024 Rev Forecast
$0.61B
2025 Rev Forecast
$0.97B
2026 Rev Forecast
$1.22B
2027 Rev Forecast
$1.54B
2028 Rev Forecast
$2.45B
2029 Rev Forecast
$2.96B
2030 Rev Forecast
$3.46B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
4568 Stock Forecast Daiichi Sankyo Company Outperform 18
¥4.07k Buy/Sell ¥0.00 35.30%
SGEN Stock Forecast Seagen Hold 6
$195.38 Buy/Sell $167.40 -20.67%
ALNY Stock Forecast Alnylam Pharmaceuticals Inc Outperform 7
$193.67 Buy/Sell $244.18 29.60%

Ionis Pharmaceuticals Dividend per Share Forecast for 2023 - 2025 - 2030

2023 DPS Forecast
$0.00
2024 DPS Forecast
$0.00
2025 DPS Forecast
$0.00
2026 DPS Forecast
$0.00
2027 DPS Forecast
$0.00
2028 DPS Forecast
$0.00
2029 DPS Forecast
$0.00
2030 DPS Forecast
$0.00
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
BMRN Stock Forecast BioMarin Pharmaceutical Outperform 10
$93.36 Buy/Sell $115.45 28.53%
INCY Stock Forecast Incyte Outperform 9
$62.54 Buy/Sell $88.18 37.51%
SRPT Stock Forecast Sarepta Therapeutics Outperform 6
$125.16 Buy/Sell $139.65 21.44%

Ionis Pharmaceuticals Free Cash Flow Forecast for 2023 - 2025 - 2030

In the last two years, Ionis Pharmaceuticals's Free Cash Flow has decreased by 94.01%, from $314.72M to $18.84M. For the next year, 4 analysts project Ionis Pharmaceuticals's Free Cash Flow to drop by 1828.13%, reaching $-325.58M. Over the next eight years, experts anticipate that Free Cash Flow growth for Ionis Pharmaceuticals will be 5051.27%.

2023 FCF Forecast
$-325580000.00
2024 FCF Forecast
$-329030000.00
2025 FCF Forecast
$-64770000.00
2026 FCF Forecast
$0.38B
2027 FCF Forecast
$0.84B
2028 FCF Forecast
$1.14B
2029 FCF Forecast
$0.84B
2030 FCF Forecast
$0.97B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
JAZZ Stock Forecast Jazz Pharmaceuticals Outperform 14
$158.79 Buy/Sell $0.00 25.95%
EXEL Stock Forecast Exelixis Outperform 16
$19.19 Buy/Sell $24.94 30.28%
4516 Stock Forecast Nippon Shinyaku Outperform 18
¥7.07k Buy/Sell ¥0.00 55.59%

Ionis Pharmaceuticals Net Income Forecast for 2023 - 2025 - 2030

In the last two years, Ionis Pharmaceuticals has seen a decline in its Net Income, from $278.14M to $-28.60M – a 110.28% decrease. In the next year, analysts believe that Net Income will reach $-263.01M – an increase of 819.62%. By 2030, professionals believe that Ionis Pharmaceuticals's Net Income will have decreased by 1596.08%, falling to $427.88M.

2023 NI Forecast
$-263010000.00
2024 NI Forecast
$-324740000.00
2025 NI Forecast
$-214000000.00
2026 NI Forecast
$-150500000.00
2027 NI Forecast
$1.42B
2028 NI Forecast
$1.86B
2029 NI Forecast
$2.31B
2030 NI Forecast
$0.43B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
DCPH Stock Forecast Deciphera Pharmaceuticals Hold 6
$14.08 Buy/Sell $0.00 -28.98%
STOK Stock Forecast Stoke Therapeutics Buy 4
$12.17 Buy/Sell $61.44 327.28%
DYN Stock Forecast Dyne Therapeutics Buy 5
$12.81 Buy/Sell $0.00 79.55%

Ionis Pharmaceuticals EBITDA Forecast for 2023 - 2025 - 2030

In the last two years, Ionis Pharmaceuticals's EBITDA has fallen from $382.56M to $14.26M – a 96.27% decrease. According to 4 prominent analysts, Ionis Pharmaceuticals's EBITDA will fall by 1411.08% in the next year, reaching $-186.96M. By 2030, professionals believe that Ionis Pharmaceuticals's EBITDA will decrease by 1688.40%, reaching $-226.51M – a concerning trend for the company.

2023 EBITDA Forecast
$-186960000.00
2024 EBITDA Forecast
$-284110000.00
2025 EBITDA Forecast
$-114700000.00
2026 EBITDA Forecast
$-199249193.33
2027 EBITDA Forecast
$-246457968.87
2028 EBITDA Forecast
$-317207836.47
2029 EBITDA Forecast
$-228516525.39
2030 EBITDA Forecast
$-226505579.97

Ionis Pharmaceuticals EBIT Forecast for 2023 - 2025 - 2030

Ionis Pharmaceuticals's EBIT has decreased In the last two years, from $368.11M to $-3.58M – a 100.97% drop. In the next year, analysts are expecting an increase in EBIT, predicting it will reach $-383.30M – an increase of 10606.70%. In 2030, professionals predict that Ionis Pharmaceuticals's EBIT will decrease by 45803.07%, to $1.64B.

2023 EBIT Forecast
$-383300000.00
2024 EBIT Forecast
$-453930000.00
2025 EBIT Forecast
$-193770000.00
2026 EBIT Forecast
$-48310000.00
2027 EBIT Forecast
$0.34B
2028 EBIT Forecast
$0.93B
2029 EBIT Forecast
$1.28B
2030 EBIT Forecast
$1.64B

Ionis Pharmaceuticals EPS Price Prediction Forecast for 2023 - 2025 - 2030

Ionis Pharmaceuticals's EPS has decreased by 62.56% In the last two years, from $2.19 to $0.82. In the following year, the 8 analysts surveyed believe that Ionis Pharmaceuticals's EPS will decrease by 326.83%, reaching $-1.86. Looking ahead to eight years, experts forecast that EPS will grow by 751.22%.

2023 EPS Forecast
$-1.86
2024 EPS Forecast
$-1.88
2025 EPS Forecast
$-0.57
2026 EPS Forecast
$1.02
2027 EPS Forecast
$9.21
2028 EPS Forecast
$12.33
2029 EPS Forecast
$12.38
2030 EPS Forecast
$6.98